Clinical Trial of YHD1119 in Patients With Peripheral Neuropathic Pain

NCT02985216 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

371

Enrollment

INDUSTRY

Sponsor class

Conditions

Peripheral Neuropathic Pain

Interventions

DRUG: YHD1119
DRUG: Lyrica

Sponsor

Yuhan Corporation